SLD logo

Saluda Medical, Inc. Stock Price

ASX:SLD Community·AU$304.9m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

SLD Share Price Performance

AU$1.21
-0.06 (-4.72%)
AU$1.21
-0.06 (-4.72%)
Price AU$1.21

SLD Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk and slightly overvalued.

3 Risks
2 Rewards

Saluda Medical, Inc. Key Details

US$70.4m

Revenue

US$37.6m

Cost of Revenue

US$32.8m

Gross Profit

US$182.1m

Other Expenses

-US$149.3m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.59
46.56%
-212.21%
-190.7%
View Full Analysis

About SLD

Founded
2011
Employees
n/a
CEO
Barry Regan
WebsiteView website
www.saludamedical.com

Saluda Medical, Inc., a medical device company, develops Evoke, an investigational device for the neuromodulation industry in the United States, Australia, the United Kingdom, and the Netherlands. The company develops a closed-loop spinal cord stimulation system that measures the spinal cord's response to stimulation and adjusts on every pulse to optimize activation within the patient's therapeutic window. It also offers an application to sense, measure, and adjust the pulse. The company was founded in 2011 and is based in Bloomington, Minnesota.

Recent SLD News & Updates

Recent updates

No updates